ADVANCES IN NANOPARTICLE-BASED DRUG DELIVERY SYSTEMS FOR  CROSSING THE BLOOD-BRAIN BARRIER: TARGETED STRATEGIES FOR  TREATING ALZHEIMER’S AND PARKINSON’S DISEASES

Dr Yashesh Shastri, Kushwah Prakash Kumar, Mr Dhaval Patel, Anuj Srivastava, Dr.Krunal Nagar

ADVANCES IN NANOPARTICLE-BASED DRUG DELIVERY SYSTEMS FOR CROSSING THE BLOOD-BRAIN BARRIER: TARGETED STRATEGIES FOR TREATING ALZHEIMER’S AND PARKINSON’S DISEASES

Authors

Dr Yashesh Shastri, Kushwah Prakash Kumar, Mr Dhaval Patel, Anuj Srivastava, Dr.Krunal Nagar

Keywords:

Blood-brain barrier (BBB), Nanoparticle-based drug delivery, Neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease, Nanoparticles, Liposomes, Solid lipid nanoparticles (SLNs), Dendrimers, Targeted drug delivery, Surface Blood-brain barrier (BBB), Nanoparticle-based drug delivery, Neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease, Nanoparticles, Liposomes, Solid lipid nanoparticles (SLNs), Dendrimers, Targeted drug delivery, Surface modification.modification.

Abstract

The blood-brain barrier (BBB) is a formidable obstacle in the development of effective therapeutic agents forneurological disorders, including Alzheimer's and Parkinson's diseases. Nanoparticle-based drug delivery systems have emerged as a promising strategy

References

Wang, S. et al. The expanding burden of neurodegenerative diseases. Aging and Disease 15(3) (2024). aginganddisease.org+1

Downloads

Published

2025-11-20

How to Cite

Dr Yashesh Shastri, Kushwah Prakash Kumar, Mr Dhaval Patel, Anuj Srivastava, Dr.Krunal Nagar. (2025). ADVANCES IN NANOPARTICLE-BASED DRUG DELIVERY SYSTEMS FOR CROSSING THE BLOOD-BRAIN BARRIER: TARGETED STRATEGIES FOR TREATING ALZHEIMER’S AND PARKINSON’S DISEASES . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 3338–3357. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1208